Summit Trail Advisors’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,350	Closed	-$50K	–	390
2018 Q2	$50K	Buy	+1,350	New	+$50K	0.02%	306
2018 Q1	–	Sell	-1,840	Closed	-$70K	–	1220
2017 Q4	$70K	Buy	+1,840	New	+$70K	0.01%	728